Seattle, WA 的 第二型糖尿病 臨床試驗
8 項針對 第二型糖尿病 的研究正在 Seattle（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
招募中歡迎健康志工
- University of Washington, Seattle
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Seattle
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Seattle
- Research Site, Seattle
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
招募中3 期
- Seattle Children's Research Institute, Seattle
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
招募中3 期
- Seattle Children's Hospital, Seattle
Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
招募中
- Seattle Children's Hospital, Seattle
- University of Washington Medicine Diabetes Institute, Seattle
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
招募中觀察性研究歡迎健康志工
- Seattle Children's Hospital, Seattle
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
招募中4 期
- University of Washington - Harborview Medical Center, Seattle
其他城市的 第二型糖尿病 試驗
- San Antonio, TX37 項研究
- Houston, TX31 項研究
- Orlando, FL24 項研究
- Boston, MA20 項研究
- Miami, FL19 項研究
- Chicago, IL19 項研究
- Dallas, TX19 項研究
- Columbus, OH18 項研究
- Las Vegas, NV18 項研究
- Atlanta, GA17 項研究
- San Diego, CA17 項研究
- Los Angeles, CA16 項研究
Seattle 的其他研究
- 非小細胞肺癌53 項研究
- 癌症（所有類型）49 項研究
- 前列腺癌42 項研究
- 急性髓系白血病40 項研究
- 乳癌39 項研究
- 轉移性癌症39 項研究
- 大腸直腸癌34 項研究
- 肺癌33 項研究
- 卵巢癌30 項研究
- 多發性骨髓瘤22 項研究
- 骨髓增生異常症候群21 項研究
- 急性淋巴母細胞性白血病21 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。